{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T23:18:23Z","timestamp":1768864703403,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30AI124414"],"award-info":[{"award-number":["P30AI124414"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10461-025-04859-9","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T02:44:04Z","timestamp":1760409844000},"page":"204-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PrEP Prescription Lengths: Associations with Patient Retention, On-Time Renewal and Demographics"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2113-9596","authenticated-orcid":false,"given":"Lila","family":"Starbuck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4977-005X","authenticated-orcid":false,"given":"Alison J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9123-6082","authenticated-orcid":false,"given":"Bryant N.","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Beil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5603-9823","authenticated-orcid":false,"given":"Viraj V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1644-1076","authenticated-orcid":false,"given":"Sarit A.","family":"Golub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"4859_CR1","unstructured":"CDC. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States. (2021 Update) \u2013 A Clinical Practice Guideline. 2021. https:\/\/stacks.cdc.gov\/view\/cdc\/112360"},{"key":"4859_CR2","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1038\/s41591-023-02564-5","volume":"29","author":"M Moore","year":"2023","unstructured":"Moore M, Stansfield S, Donnell DJ, et al. Efficacy estimates of oral pre-exposure prophylaxis for HIV prevention in cisgender women with partial adherence. Nat Med. 2023;29:2748\u201352. https:\/\/doi.org\/10.1038\/s41591-023-02564-5.","journal-title":"Nat Med"},{"issue":"5","key":"4859_CR3","doi-asserted-by":"publisher","first-page":"e048478","DOI":"10.1136\/bmjopen-2020-048478","volume":"12","author":"E O Murchu","year":"2022","unstructured":"O Murchu E, Marshall L, Teljeur C, et al. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ Open. 2022;12(5):e048478. https:\/\/doi.org\/10.1136\/bmjopen-2020-048478.","journal-title":"BMJ Open"},{"issue":"3","key":"4859_CR4","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/qai.0000000000003272","volume":"94","author":"A Aryal","year":"2023","unstructured":"Aryal A, Leibowitz A, Comulada A. PrEP use and HIV incidence among youth At-Risk for HIV infection in Los Angeles and new orleans: findings from ATN 149. JAIDS J Acquir Immune Defic Syndr. 2023;94(3):220\u20136. https:\/\/doi.org\/10.1097\/qai.0000000000003272.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"4859_CR5","doi-asserted-by":"publisher","unstructured":"Spinelli MA, Laborde N, Kinley P, et al. Missed opportunities to prevent HIV infections among pre-exposure prophylaxis users: a population-based mixed methods study, San Francisco, United States. J Int AIDS Soc. 2020;23(4). https:\/\/doi.org\/10.1002\/jia2.25472.","DOI":"10.1002\/jia2.25472"},{"issue":"4","key":"4859_CR6","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1016\/S2352-3018(22)00030-3","volume":"9","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li C, Xu J, et al. Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis. Lancet HIV. 2022;9(4):e254\u201368. https:\/\/doi.org\/10.1016\/S2352-3018(22)00030-3. 2022\/04\/01.","journal-title":"Lancet HIV"},{"issue":"7","key":"4859_CR7","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s10461-018-2296-x","volume":"23","author":"AJ Lankowski","year":"2019","unstructured":"Lankowski AJ, Bien-Gund CH, Patel VV, Felsen UR, Silvera R, Blackstock OJ. PrEP in the real world: predictors of 6-Month retention in a diverse urban cohort. AIDS Behav Jul. 2019;23(7):1797\u2013802. https:\/\/doi.org\/10.1007\/s10461-018-2296-x.","journal-title":"AIDS Behav Jul"},{"issue":"5","key":"4859_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1521\/aeap.2018.30.5.393","volume":"30","author":"MA Hevey","year":"2018","unstructured":"Hevey MA, Walsh JL, Petroll AE, PrEP Continuation HIV. Rates, and delivery of preventive care in a Clinic-Based cohort. AIDS Educ Prev Oct. 2018;30(5):393\u2013405. https:\/\/doi.org\/10.1521\/aeap.2018.30.5.393.","journal-title":"AIDS Educ Prev Oct"},{"issue":"12","key":"4859_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10508-021-02086-6","volume":"51","author":"RA Fikslin","year":"2022","unstructured":"Fikslin RA, Goldberg AJ, Gesselman AN, et al. Changes in utilization of PrEP and birth control during COVID-19: A mixed-methods analysis. Arch Sex Behav. 2022;51(12):365\u201381. https:\/\/doi.org\/10.1007\/s10508-021-02086-6.","journal-title":"Arch Sex Behav"},{"issue":"4","key":"4859_CR10","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1097\/qai.0000000000002054","volume":"1","author":"J Zucker","year":"2019","unstructured":"Zucker J, Carnevale C, Richards P, et al. Predictors of disengagement in care for individuals receiving Pre-exposure prophylaxis (PrEP). J Acquir Immune Defic Syndr Aug. 2019;1(4):e104\u20138. https:\/\/doi.org\/10.1097\/qai.0000000000002054.","journal-title":"J Acquir Immune Defic Syndr Aug"},{"issue":"11","key":"4859_CR11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/09564624231179276","volume":"34","author":"S Herns","year":"2023","unstructured":"Herns S, Panwala R, Pfeil A, et al. Predictors of PrEP retention in at risk patients seen at a HIV primary care clinic in San Diego. Int J STD AIDS Oct. 2023;34(11):785\u201390. https:\/\/doi.org\/10.1177\/09564624231179276.","journal-title":"Int J STD AIDS Oct"},{"issue":"2","key":"4859_CR12","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s10508-023-02721-4","volume":"2024\/02\/01","author":"T Arnold","year":"2024","unstructured":"Arnold T, Giorlando KK, Barnett AP, et al. Social, structural, behavioral, and clinical barriers influencing Pre-exposure prophylaxis (PrEP) use among young black men who have sex with men in the south: A qualitative update to a 2016 study. Arch Sex Behav. 2024;2024\/02\/01(2):785\u201397. https:\/\/doi.org\/10.1007\/s10508-023-02721-4.","journal-title":"Arch Sex Behav"},{"issue":"5","key":"4859_CR13","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/13691058.2020.1720297","volume":"23","author":"LA Nydegger","year":"2021","unstructured":"Nydegger LA, Dickson-Gomez J, Ko Ko T. Structural and syndemic barriers to PrEP adoption among black women at high risk for HIV: a qualitative exploration. Cult Health Sex. 2021;23(5):659\u201373. https:\/\/doi.org\/10.1080\/13691058.2020.1720297.","journal-title":"Cult Health Sex"},{"issue":"7","key":"4859_CR14","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s10461-021-03159-2","volume":"25","author":"A Ogunbajo","year":"2021","unstructured":"Ogunbajo A, Storholm ED, Ober AJ, et al. Multilevel barriers to HIV PrEP uptake and adherence among black and hispanic\/latinx transgender women in Southern California. AIDS Behav. 2021;25(7):2301\u201315. https:\/\/doi.org\/10.1007\/s10461-021-03159-2.","journal-title":"AIDS Behav"},{"issue":"3","key":"4859_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1377\/hlthaff.2023.00867","volume":"43","author":"Y Guo","year":"2024","unstructured":"Guo Y, Westmoreland DA, D\u2019Angelo A, et al. PrEP discontinuation in a US National cohort of sexual and gender minority populations, 2017\u20132022. Health Aff. 2024;43(3):443\u201351. https:\/\/doi.org\/10.1377\/hlthaff.2023.00867.","journal-title":"Health Aff"},{"issue":"5S1","key":"4859_CR16","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1016\/j.amepre.2021.05.040","volume":"61","author":"EE Chasco","year":"2021","unstructured":"Chasco EE, Shafer C, Dillon DMB, Owens S, Ohl ME, Hoth AB. Bringing Iowa teleprep to scale: A qualitative evaluation. Am J Prev Med. 2021;61(5S1):S108\u201317. https:\/\/doi.org\/10.1016\/j.amepre.2021.05.040.","journal-title":"Am J Prev Med"},{"issue":"12","key":"4859_CR17","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1007\/s10461-021-03353-2","volume":"25","author":"SM Walters","year":"2021","unstructured":"Walters SM, Platt J, Anakaraonye A, et al. Considerations for the design of pre-exposure prophylaxis (PrEP) interventions for women: lessons learned from the implementation of a novel PrEP intervention. AIDS Behav. 2021;25(12):3987\u201399.","journal-title":"AIDS Behav"},{"key":"4859_CR18","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/j.cjca.2015.07.111","volume":"10\/01","author":"N Montazeri","year":"2015","unstructured":"Montazeri N, Anderson C, Rao-Melacini P, Ivers N, Natarajan M, Schwalm J-D, IS ASSOCIATED WITH HIGHER MEDICATION ADHERENCE: A POST-HOC SUB-STUDY OF THE DERLA-STEMI TRIAL. Can J Cardiol. 2015;10\/01:31:S46\u20137. https:\/\/doi.org\/10.1016\/j.cjca.2015.07.111.","journal-title":"Can J Cardiol"},{"key":"4859_CR19","doi-asserted-by":"publisher","unstructured":"Rymer JA, Fonseca E, Bhandary DD, Kumar D, Khan ND, Wang TY. Difference in Medication Adherence Between Patients Prescribed a 30-Day Versus 90\u2010Day Supply After Acute Myocardial Infarction. J Am Heart Association. 2021;10(1). https:\/\/doi.org\/10.1161\/jaha.119.016215.","DOI":"10.1161\/jaha.119.016215"},{"key":"4859_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ijcard.2014.12.058","volume":"1","author":"MC Wong","year":"2015","unstructured":"Wong MC, Tam WW, Wang HH, et al. Duration of initial antihypertensive prescription and medication adherence: a cohort study among 203,259 newly diagnosed hypertensive patients. Int J Cardiol Mar. 2015;1:182:503\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2014.12.058.","journal-title":"Int J Cardiol Mar"},{"issue":"1","key":"4859_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/1472-6963-13-192","volume":"13","author":"PM Wilson","year":"2013","unstructured":"Wilson PM, Kataria N, McNeilly E. Patient and carer experience of obtaining regular prescribed medication for chronic disease in the English National Health Service: a qualitative study. BMC Health Serv Res. 2013;13(1):192. https:\/\/doi.org\/10.1186\/1472-6963-13-192.","journal-title":"BMC Health Serv Res"},{"key":"4859_CR22","doi-asserted-by":"publisher","unstructured":"Laborde ND, Kinley PM, Spinelli M, et al. Understanding PrEP Persistence: Provider and Patient Perspectives. AIDS and Behaviour. 2020;24(9):2509\u201319. https:\/\/doi.org\/10.1007\/s10461-020-02807-3.","DOI":"10.1007\/s10461-020-02807-3"},{"issue":"13","key":"4859_CR23","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1093\/ajhp\/61.13.1375","volume":"61","author":"ME Domino","year":"2004","unstructured":"Domino ME, Olinick J, Sleath B, Leinwand S, Byrns PJ, Carey T. Restricting patients\u2019 medication supply to one month: saving or wasting money? Am J Health-System Pharm. 2004;61(13):1375\u20139. https:\/\/doi.org\/10.1093\/ajhp\/61.13.1375.","journal-title":"Am J Health-System Pharm"},{"issue":"669","key":"4859_CR24","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.3399\/bjgp18x695501","volume":"68","author":"S King","year":"2018","unstructured":"King S, Miani C, Exley J, Larkin J, Kirtley A, Payne RA. Impact of issuing longer- versus shorter-duration prescriptions: a systematic review. Br J Gen Pract. 2018;68(669):e286\u201392. https:\/\/doi.org\/10.3399\/bjgp18x695501.","journal-title":"Br J Gen Pract"},{"issue":"78","key":"4859_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta21780","volume":"21","author":"C Miani","year":"2017","unstructured":"Miani C, Martin A, Exley J, et al. Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling. Health Technol Assess. 2017;21(78):1\u2013128. https:\/\/doi.org\/10.3310\/hta21780.","journal-title":"Health Technol Assess"},{"issue":"6","key":"4859_CR26","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00127-020-01989-4","volume":"56","author":"RS McIntyre","year":"2021","unstructured":"McIntyre RS, Chen VC-H, Lee Y, et al. The influence of prescriber and patient gender on the prescription of benzodiazepines: evidence for stereotypes and biases? Soc Psychiatry Psychiatr Epidemiol. 2021;56(6):1083\u20139. https:\/\/doi.org\/10.1007\/s00127-020-01989-4.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"4","key":"4859_CR27","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1056\/nejmsa2034159","volume":"385","author":"NE Morden","year":"2021","unstructured":"Morden NE, Chyn D, Wood A, Meara E. Racial inequality in prescription opioid receipt \u2014 role of individual health systems. N Engl J Med. 2021;385(4):342\u201351. https:\/\/doi.org\/10.1056\/nejmsa2034159.","journal-title":"N Engl J Med"},{"issue":"5","key":"4859_CR28","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.annemergmed.2019.05.018","volume":"74","author":"RJ Romanelli","year":"2019","unstructured":"Romanelli RJ, Shen Z, Szwerinski N, Scott A, Lockhart S, Pressman AR. Racial and ethnic disparities in opioid prescribing for long bone fractures at discharge from the emergency department: A Cross-sectional analysis of 22 centers from a health care delivery system in Northern California. Ann Emerg Med. 2019;74(5):622\u201331. https:\/\/doi.org\/10.1016\/j.annemergmed.2019.05.018.","journal-title":"Ann Emerg Med"},{"issue":"2","key":"4859_CR29","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/0033354920904085","volume":"135","author":"NW Furukawa","year":"2020","unstructured":"Furukawa NW, Smith DK, Gonzalez CJ, et al. Evaluation of algorithms used for PrEP surveillance using a reference population from new York city, July 2016\u2013June 2018. Public Health Reports\u00ae. 2020;135(2):202\u201310. https:\/\/doi.org\/10.1177\/0033354920904085.","journal-title":"Public Health Reports\u00ae"},{"issue":"2","key":"4859_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/jamia\/ocab136","volume":"12","author":"CA Kronk","year":"2022","unstructured":"Kronk CA, Everhart AR, Ashley F, et al. Transgender data collection in the electronic health record: current concepts and issues. J Am Med Inf Assoc Jan. 2022;12(2):271\u201384. https:\/\/doi.org\/10.1093\/jamia\/ocab136.","journal-title":"J Am Med Inf Assoc Jan"},{"issue":"3","key":"4859_CR31","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1016\/S2352-3018(20)30271-X","volume":"8","author":"J Ambrosioni","year":"2021","unstructured":"Ambrosioni J, Petit E, Liegeon G, Laguno M, Mir\u00f3 JM. Primary HIV-1 infection in users of pre-exposure prophylaxis. Lancet HIV. 2021;8(3):e166\u201374. https:\/\/doi.org\/10.1016\/S2352-3018(20)30271-X.","journal-title":"Lancet HIV"},{"issue":"6","key":"4859_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40265-019-01108-x","volume":"79","author":"KM Gibas","year":"2019","unstructured":"Gibas KM, van den Berg P, Powell VE, Krakower DS. Drug resistance during HIV Pre-Exposure prophylaxis. Drugs 2019\/04\/01. 2019;79(6):609\u201319. https:\/\/doi.org\/10.1007\/s40265-019-01108-x.","journal-title":"Drugs 2019\/04\/01"},{"issue":"4","key":"4859_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/qad.0000000000003143","volume":"15","author":"N Girometti","year":"2022","unstructured":"Girometti N, McCormack S, Tittle V, McOwan A, Whitlock G. Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes. Aids Mar. 2022;15(4):561\u20136. https:\/\/doi.org\/10.1097\/qad.0000000000003143.","journal-title":"Aids Mar"},{"issue":"3","key":"4859_CR34","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/qai.0000000000002952","volume":"1","author":"ZD Unger","year":"2022","unstructured":"Unger ZD, Golub SA, Borges C, Edelstein ZR, Hedberg T, Myers J. Reasons for PrEP discontinuation after navigation at sexual health clinics: interactions among systemic barriers, behavioral relevance, and medication concerns. J Acquir Immune Defic Syndr Jul. 2022;1(3):316\u201324. https:\/\/doi.org\/10.1097\/qai.0000000000002952.","journal-title":"J Acquir Immune Defic Syndr Jul"},{"issue":"5","key":"4859_CR35","doi-asserted-by":"publisher","first-page":"ofae254","DOI":"10.1093\/ofid\/ofae254","volume":"11","author":"J Baron","year":"2024","unstructured":"Baron J, Tchelidze T, LaBrot B, et al. High rates of missed HIV testing among oral PrEP users in the united States from 2018\u20132021: A National assessment on compliance with HIV testing recommendations of the CDC PrEP guidelines. Open Forum Infect Dis May. 2024;11(5):ofae254. https:\/\/doi.org\/10.1093\/ofid\/ofae254.","journal-title":"Open Forum Infect Dis May"},{"issue":"4","key":"4859_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/08897077.2019.1640833","volume":"40","author":"B Allen","year":"2019","unstructured":"Allen B, Nolan ML, Paone D. Underutilization of medications to treat opioid use disorder: what role does stigma play? Subst Abus. 2019;40(4):459\u201365. https:\/\/doi.org\/10.1080\/08897077.2019.1640833.","journal-title":"Subst Abus"},{"key":"4859_CR37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ajem.2021.10.017","volume":"51","author":"E Wing","year":"2022","unstructured":"Wing E, Saadat S, Bhargava R, Yun H, Chakravarthy B. Racial disparities in opioid prescriptions for fractures in the pediatric population. Am J Emerg Med. 2022;51:210\u20133. https:\/\/doi.org\/10.1016\/j.ajem.2021.10.017.","journal-title":"Am J Emerg Med"},{"key":"4859_CR38","doi-asserted-by":"publisher","unstructured":"Sullivan PS, Hall E, Bradley H, Russell ES, Woodyatt CR. Inequities in PrEP annualized pill-day coverage, United States, 2018\u20132022: a cross-sectional pharmacoequity analysis. J Int AIDS Soc. 2025;28(5). https:\/\/doi.org\/10.1002\/jia2.26459.","DOI":"10.1002\/jia2.26459"},{"key":"4859_CR39","unstructured":"Duddy-Tenbrunsel R, Edelin ND, Donthi S, Cole M, Bekele B, Brantley K. Medicaid networks more than 60% narrower than commercial in some areas. Avalere Health; 2021."},{"issue":"12","key":"4859_CR40","doi-asserted-by":"publisher","first-page":"e2029419","DOI":"10.1001\/jamanetworkopen.2020.29419","volume":"3","author":"JA Graves","year":"2020","unstructured":"Graves JA, Nshuti L, Everson J, et al. Breadth and exclusivity of hospital and physician networks in US insurance markets. JAMA Netw Open. 2020;3(12):e2029419\u20132029419. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.29419.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"4859_CR41","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1007\/s10461-022-03941-w","volume":"27","author":"C Hong","year":"2023","unstructured":"Hong C. Characterizing the impact of the COVID-19 pandemic on HIV PrEP care: A review and synthesis of the literature. AIDS Behav 2023\/07\/01. 2023;27(7):2089\u2013102. https:\/\/doi.org\/10.1007\/s10461-022-03941-w.","journal-title":"AIDS Behav 2023\/07\/01"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04859-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04859-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04859-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T10:59:53Z","timestamp":1768820393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04859-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4859"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04859-9","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"31 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Albert Einstein College of Medicine Institutional Review Board, with a waiver of informed consent. The study was deemed to meet criteria for exemption from IRB review at CUNY, because the CUNY research team was conducting only secondary analyses of de-identified data. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The present research involved secondary analysis of data collected in the course of routine care. A Waiver of Informed Consent was obtained from the Albert Einstein College of Medicine IRB.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}